lovetravellingoz
Enthusiast
- Joined
- Jul 13, 2006
- Posts
- 12,704
1/ I think one needs to remember that companies do not just build mRNA facilities and hope that they may be used. They also do not build these facilities for only short term use.
2/ They are Pharma Companies who develop their own products and then have the plants to manufacturer their own products. Pfizer has allowed one French company to manufacturer it for a temporary period. That was after that companies own candidate was delayed.
3/ Also it is not simply a matter of just building the mRNA Facility. A huge issue at present is also the extreme short supply of the specialised single-use consumable plastic bags that go into the reactor vessels during vaccine production are in short supply, and the equally rare specialised lipids that are required. Only a few companies in the world manufacture these specialised lipids. Without access to everything that you need you would have a mRNA facility unable to do anything.
4/ Building a new facility from scratch is a minimum of 6 months if you are a company that know what you are doing.
5/ So if you want a mRNA facility here you have to have a company with actual and/or potential mRNA products/candidates that they can manufacturer and sell to the world over the long-term. A 12 month manufacturing contract is not going to interest anyone to build a plant from scratch.
6/ The mRNA vaccines could have just have easily been the ones to have had a problem. Indeed they still may.
2/ They are Pharma Companies who develop their own products and then have the plants to manufacturer their own products. Pfizer has allowed one French company to manufacturer it for a temporary period. That was after that companies own candidate was delayed.
3/ Also it is not simply a matter of just building the mRNA Facility. A huge issue at present is also the extreme short supply of the specialised single-use consumable plastic bags that go into the reactor vessels during vaccine production are in short supply, and the equally rare specialised lipids that are required. Only a few companies in the world manufacture these specialised lipids. Without access to everything that you need you would have a mRNA facility unable to do anything.
4/ Building a new facility from scratch is a minimum of 6 months if you are a company that know what you are doing.
5/ So if you want a mRNA facility here you have to have a company with actual and/or potential mRNA products/candidates that they can manufacturer and sell to the world over the long-term. A 12 month manufacturing contract is not going to interest anyone to build a plant from scratch.
6/ The mRNA vaccines could have just have easily been the ones to have had a problem. Indeed they still may.
Last edited: